Exclusion of the left atrial appendage with a novel device: Early results of a multicenter trial Gorav Ailawadi, MD, Marc W. Gerdisch, MD, Richard L. Harvey, MD, Robert L. Hooker, MD, Ralph J. Damiano, MD, Thomas Salamon, MD, Michael J. Mack, MD The Journal of Thoracic and Cardiovascular Surgery Volume 142, Issue 5, Pages 1002-1009.e1 (November 2011) DOI: 10.1016/j.jtcvs.2011.07.052 Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 Enrollment and follow-up scheme of patients enrolled in the EXCLUDE trial. f/u, Follow-up; CT, computed tomography; TEE, transesophageal echocardiography. The Journal of Thoracic and Cardiovascular Surgery 2011 142, 1002-1009.e1DOI: (10.1016/j.jtcvs.2011.07.052) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions
Figure 2 Intraoperative TEE demonstrating (A) patent LAA before AtriClip (Atricure Inc, Westchester, Ohio) device placement (red arrow) and (B) echocardiographic evidence of LAA exclusion after clip placement (orange arrow; yellow arrowheads indicate pulmonary veins). The Journal of Thoracic and Cardiovascular Surgery 2011 142, 1002-1009.e1DOI: (10.1016/j.jtcvs.2011.07.052) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions
Figure 3 CT scan (A) preoperatively demonstrating patent LAA with contrast filling lumen and (B) postoperatively at 3 months after AtriClip device insertion demonstrating endovascular exclusion of the LAA. The Journal of Thoracic and Cardiovascular Surgery 2011 142, 1002-1009.e1DOI: (10.1016/j.jtcvs.2011.07.052) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions